Doxycyclin Stada

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Doxycyclin Stada

Quick Facts

Property Description
Active ingredient Doxycycline (hyclate or hydrochloride)
Form Tablets, Capsules
Pharmacological class Tetracycline Antibiotic
General purpose Combating bacterial infections
Origin Semisynthetic

What Type of Medicine is Doxycyclin Stada?

Doxycyclin Stada is a specific pharmaceutical preparation whose primary active component, Doxycycline, is a prescription-only drug used to control the proliferation of various harmful bacteria. This medicine belongs specifically to the tetracycline antibiotic class, which is clinically recognized for its broad-spectrum efficacy against a wide range of susceptible microorganisms. The overarching purpose of Doxycyclin Stada is to combat the spread and progression of bacterial infections within the body. The drug’s mechanism is primarily bacteriostatic, meaning it suppresses the bacterial population by inhibiting protein synthesis, allowing the patient’s natural immune system to clear the remaining infection.

Composition and Origin of Doxycycline

The therapeutic action of Doxycyclin Stada is derived from the single active ingredient, which is Doxycycline, typically supplied as the hyclate or hydrochloride salt. The active compound is classified as semisynthetic, indicating that its structure is chemically modified from naturally occurring tetracycline compounds. Doxycyclin Stada is formulated for oral administration and is presented as solid pharmaceutical preparations, generally film-coated tablets or capsules, which ensures reliable and convenient delivery. As a recognized brand in various markets, Doxycyclin Stada is designed to offer a standardized, established means of administering the effective Doxycycline compound, a treatment frequently employed for conditions requiring systemic antibiotic intervention.

Regulatory References

  1. NIH: Doxycycline Hyclate

What side effects are possible with Doxycyclin Stada?

Possible side effects and safety information

The safety profile of this medicine, containing doxycycline, is defined by categories of adverse reactions documented in official regulatory sources, such as the FDA and EMA. These effects are classified by how often they may occur and the specific body system they affect (System-Organ Class or SOC).

Commonly documented effects include gastrointestinal disturbances like nausea, vomiting, and diarrhea. Another common reaction is photosensitivity, which is an exaggerated sunburn-like reaction to sun or UV light exposure.

Adverse effects are formally grouped by the system involved:

  • Gastrointestinal Disorders: Includes esophagitis and ulceration.
  • Nervous System Disorders: Documented effects include headache and the rare occurrence of Benign Intracranial Hypertension (Pseudotumor Cerebri).
  • Skin Disorders: Covers various rashes and serious reactions like Stevens-Johnson syndrome and Toxic Epidermal Necrolysis (SCARs).

Serious Adverse Reactions are explicitly documented and include the rare occurrences of Benign Intracranial Hypertension and severe cutaneous adverse reactions. The medicine is contraindicated in individuals with a known hypersensitivity to doxycycline or any other tetracycline-class antibiotic.

Population-Specific Safety Constraints

Official labels advise restrictions for specific groups. The medicine is generally not recommended for children under 8 years of age due to the risk of permanent tooth discoloration and inhibition of bone growth during the period of tooth development. It is also contraindicated during pregnancy and lactation due to potential effects on the developing fetus or infant.

Overdose and Emergency Response

Overdose Manifestations and Documented Risks

Official regulatory documents state that an overdose of Doxycycline is primarily characterized by an exaggeration of known toxic effects. These presentations typically involve severe gastrointestinal distress, including anorexia, nausea, and vomiting. Regulatory labels document the risk of Intracranial Hypertension (IH), or pseudotumor cerebri, as a serious complication of overexposure. Signs of IH include severe headache and blurred vision; prompt evaluation is warranted due to the documented risk of permanent visual loss.

Overexposure may also increase the dose-related risk of renal toxicity (rise in BUN) and hepatotoxicity. In population-specific notes, overexposure in infants may be associated with bulging fontanels, and a risk of permanent tooth discoloration is noted for children under eight years.

Required Emergency Action

Immediate medical attention is required for any severe or life-threatening symptoms. Regulatory guidance mandates that emergency services must be contacted immediately if an individual experiences collapse, a seizure, trouble breathing, or cannot be awakened.

For management, no specific antidote is known. Treatment is focused on providing symptomatic and supportive care. Procedural interventions, such as gastric lavage, may be considered based on the clinical situation and time of ingestion.

Therapeutic Uses of Doxycyclin Stada

What Doxycyclin Stada Treats: Main Uses and Benefits

Doxycyclin Stada is considered relevant in clinical settings involving susceptible bacterial pathogens and associated inflammatory processes. Its therapeutic benefit is delivered across several key health domains.

The medication is commonly used to help manage conditions presenting with systemic or localized discomfort, including bacterial infections of the respiratory, urinary, and gastrointestinal tracts. It is also considered relevant for specialized vector-borne illnesses, such as certain Rickettsial fevers and early-stage Lyme disease, and is applied in contexts involving the management of Sexually Transmitted Infections (STIs) and chronic inflammatory conditions like severe acne vulgaris and rosacea.

“The application of this medication is used to help ease the overall symptom burden associated with the conditions it treats.”

This wide-ranging application provides support that helps manage symptoms that interfere with daily comfort, contributing to general well-being during symptomatic periods. Doxycyclin Stada may assist with maintaining functional stability during symptomatic phases.

Quick Fact Relief for Symptom
Systemic Symptom Management Helps manage systemic discomfort and symptoms related to systemic imbalance from various bacterial sources.
Inflammation Applied to ease redness, papules, and pustules associated with chronic skin conditions.
Prophylaxis May be part of symptomatic management to prevent specific infections (e.g., malaria) in high-risk scenarios.

Regulatory References

  1. DailyMed official Doxycycline indications

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Doxycyclin Stada

This map summarizes the official population eligibility and non-eligibility rules for Doxycyclin Stada (Doxycycline) based strictly on authoritative governmental regulatory documents.


Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adults and Adolescents (ge 12 years); Older adults are generally permitted without special dosage adjustments.
Populations for whom use is contraindicated Individuals with known hypersensitivity to any tetracycline; Children younger than 8 years; Pregnant women; Lactating women.
Age-related eligibility rules Contraindicated in children <8 years due to the risk of permanent tooth discoloration. Use in children 8 to 12 years is conditional, reserved for severe or life-threatening infections.
Condition-specific eligibility rules Renal Impairment: Dosage modification is not necessary. Hepatic Impairment: Use requires caution.
Eligibility-related restrictions Caution is advised for patients with pre-existing conditions like Systemic Lupus Erythematosus (SLE) or Myasthenia Gravis.

Eligibility Classifications (High-Level)

Classification Official Regulatory Wording
Eligibility severity classification Contraindicated (Allergy, Age, Pregnancy); Caution/Conditional Use (Organ function, Specific Comorbidities).
Eligibility-context constraints The age contraindication is explicitly tied to the risk of permanent tooth discoloration and enamel hypoplasia during tooth development.

Resulting Eligibility Structure

Regulatory documents define who can and cannot use Doxycyclin Stada by classifying specific populations—including those based on age, immunological response, and reproductive status—as contraindicated to minimize the potential for serious developmental risks. For other populations, such as those with hepatic impairment, the label dictates conditions of caution or restricted use, while confirming general eligibility for adults and adolescents.

What should I know about interactions with other medicines?

Doxycyclin Stada’s interaction profile is governed by restrictions and required administration constraints detailed in regulatory product information. The use of Doxycycline is formally contraindicated with oral retinoids, such as Isotretinoin, due to the officially documented risk of elevated intracranial pressure.

The drug’s systemic exposure is subject to pharmacokinetic modification by enzyme-inducing anti-epilepsy medicines, including Phenytoin, Carbamazepine, and Barbiturates, which are noted to accelerate clearance and reduce the therapeutic concentration of Doxycycline. Absorption interference necessitates timing rules for certain substances.

Mineral-containing preparations like antacids, iron supplements, oral zinc, and bismuth salts must be administered with a separation interval of one to two hours to prevent chelation and a documented reduction in Doxycycline's absorption and efficacy.

Pharmacodynamic augmentation is documented with oral anticoagulants, for which Doxycycline may potentiate their effects, increasing the potential for a bleeding risk. Co-administration may also reduce the documented effectiveness of hormonal oral contraceptives. Regulatory labels advise that concurrent use with hepatotoxic agents should be avoided, though a key population-specific note indicates the absence of an anti-anabolic effect in patients with impaired renal function.

Mechanism of Action

Doxycycline works through two primary, distinct mechanisms at the biological level: a direct antibiotic effect on susceptible bacteria and a modulatory effect on host processes, specifically inflammation and tissue degradation.

Inhibits Bacterial Growth by Blocking Protein Synthesis

This mechanism targets the 30 S ribosomal subunit inside susceptible bacteria, acting as a competitive inhibitor. By binding to the ribosome, the drug blocks the process by which bacteria manufacture the proteins they require to grow and multiply. The resulting physiological effect is the arrest of microbial growth (bacteriostasis), which results in a reduction of the density of the microbial load.

Modulates Host Tissue Breakdown and Inflammation

This action is independent of the antibiotic effect and involves the drug's influence on host enzymes and inflammatory signals. Doxycycline inhibits the activity of tissue-degrading enzymes, such as Matrix Metalloproteinases (MMPs), and dampens the release of pro-inflammatory mediators. This mechanism leads to the physiological outcome of reduced inflammation and results in the maintenance of the structural integrity of connective tissues by limiting enzymatic breakdown.

Physicochemical Constraints on Bioavailability

The drug's molecule has a natural tendency to chelate (bind) to certain metal ions like Calcium, Magnesium, and Iron. This interaction occurs in the gut and forms insoluble complexes. The complex formed limits the amount of the drug available for systemic absorption. This physicochemical interaction constrains the systemic concentration of the drug available to engage its biological targets.

Dosage and Administration Information

Doxycyclin Stada must be taken exactly as prescribed by your healthcare provider. Do not exceed the prescribed dose or duration of treatment, as this may increase the risk of side effects and promote antibiotic resistance.

Administration Guidelines

  • Swallowing: Swallow the capsule or tablet whole with a full glass of water (at least 240 ml). Do not chew, crush, or break the capsule or delayed-release tablets unless specifically instructed by your pharmacist or doctor.
  • Position: To reduce the risk of esophageal irritation or ulceration, remain upright (sitting or standing) for at least 30 minutes after taking the medicine, and avoid taking it immediately before lying down.
  • With Food: While Doxycycline is generally well-absorbed, if it causes stomach upset, it may be taken with food or milk. However, it is advisable to discuss this with your doctor, as co-administration with food or milk may decrease drug absorption for some formulations.

Important Considerations

Item Guideline
Missed Dose Take the missed dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose.
Completion It is essential to complete the entire course of treatment, even if symptoms improve quickly. Stopping early can lead to treatment failure and contribute to the development of drug-resistant bacteria.
Drug Interactions Antacids (containing aluminum, calcium, or magnesium), iron supplements, and bismuth subsalicylate (e.g., Pepto-Bismol) can significantly impair Doxycycline absorption. Take Doxycyclin Stada at least 2 hours before or 2 hours after these products.

Consult your doctor or pharmacist if you have any questions regarding the correct use of your specific medication, including any special preparation instructions for children or adults who cannot swallow pills.

Recent Clinical Evidence

Doxycyclin Stada: Recent Clinical Evidence

Recent research focusing on doxycycline, the active ingredient in Doxycyclin Stada, continues to explore its efficacy across various infectious and inflammatory conditions. As a broad-spectrum tetracycline-class antibiotic, its well-established role in treating numerous bacterial infections, including respiratory, urinary tract, and sexually transmitted infections (STIs), remains a key focus of public health studies.


Expanding Research Applications

Clinical trials have been conducted to evaluate new applications, particularly in prophylaxis and inflammatory management:

  • STI Post-Exposure Prophylaxis (Doxy-PEP): Studies, particularly among high-risk groups, have evaluated the use of a post-exposure regimen for reducing the incidence of bacterial STIs, such as Chlamydia trachomatis and Treponema pallidum (syphilis). Research findings have documented significant reductions in infection rates, though monitoring for antibiotic resistance remains an important consideration.
  • Anti-inflammatory Properties: Research beyond its antimicrobial uses has investigated the drug's non-antibiotic properties, which include an ability to influence certain inflammatory pathways. This has led to studies exploring its use in managing inflammation in conditions such as rosacea and certain rheumatological disorders.

Safety Profile Monitoring

Monitoring studies continue to assess the long-term safety and tolerability profile, especially in cases of prolonged use for chronic conditions like acne or rosacea, or for malaria prophylaxis. Common research findings relate to gastrointestinal upset and photosensitivity (increased skin sensitivity to sunlight). Studies comparing different dosages and formulations have been conducted to evaluate their impact on these common adverse events.

Frequently Asked Questions (FAQ)

Common questions about Doxycyclin Stada (FAQ)

Q: How quickly does Doxycyclin Stada start working for an infection?

A: Doxycycline, the active ingredient, generally begins its action of inhibiting bacteria and reducing inflammation within the first 24 to 48 hours after starting the medicine. However, the time it takes for a person to feel relief from symptoms can vary widely. Symptom improvement depends on the specific type of infection being treated and how severe it is.

Q: Can Doxycyclin Stada be taken with common pain relievers like ibuprofen?

A: Official regulatory information does not typically list specific, formal interactions between doxycycline and common over-the-counter pain relievers like ibuprofen (a type of NSAID). However, caution is advised for gastrointestinal effects. It is important to discuss all medications and products with a healthcare provider before use.

Q: Can Doxycyclin Stada cause dizziness or lightheadedness?

A: Official product information on Doxycycline documents effects on the Nervous System. Symptoms like dizziness have been reported, and serious effects like severe headaches, which are associated with Benign Intracranial Hypertension, are documented in official safety information. Patients should be informed of this possibility.

Q: Can Doxycyclin Stada cause headaches?

A: Yes, regulatory documents list headaches as a documented adverse effect of Doxycycline, classified under Nervous System Disorders. Experiencing persistent or severe headaches is a situation where consultation with a healthcare professional is generally recommended.

Q: Is it normal for Doxycyclin Stada to cause stomach upset?

A: Yes, gastrointestinal disturbances such as nausea, vomiting, or diarrhea are commonly documented side effects. To potentially lessen stomach upset, some regulatory guidance suggests taking the medication with food or milk. This should be discussed with a doctor, as there is a risk that co-administration with food or milk may decrease drug absorption.

Q: Does alcohol interact negatively with Doxycyclin Stada?

A: Regulatory sources advise caution regarding the concurrent use of Doxycycline and alcohol. Heavy alcohol consumption can potentially increase the likelihood of experiencing common side effects like nausea and vomiting, and may put additional strain on the liver.

Q: How long do I usually have to take Doxycyclin Stada for a standard course of treatment?

A: The required duration of treatment varies significantly based on the condition being treated, such as several days for certain infections or much longer for specific uses like malaria prophylaxis. The healthcare provider determines the exact course length needed to successfully treat a specific condition and prevent antibiotic resistance.

Q: What signs indicate an allergic reaction to Doxycyclin Stada?

A: Signs of a serious allergic reaction, as documented in official safety information, can include swelling of the face, lips, or tongue, difficulty breathing, a fast heartbeat, or developing hives and severe skin blistering. These symptoms are serious and generally warrant immediate emergency medical attention.

Q: How does Doxycyclin Stada affect the natural gut flora?

A: As a broad-spectrum antibiotic, Doxycycline works by inhibiting the growth of susceptible bacteria, but this action can also disrupt the natural balance of beneficial bacteria in the gut. This disruption is a common cause of antibiotic-associated side effects such as diarrhea or the potential overgrowth of other organisms.

Q: Can taking Doxycyclin Stada cause yeast infections?

A: Yes, official consumer information for Doxycycline documents yeast infections, such as oral thrush or vaginal candidiasis, as a possible side effect. This occurs due to the antibiotic disrupting the natural bacterial balance in the body, allowing yeast to overgrow.

Q: What is the typical expectation for symptom improvement on Doxycyclin Stada?

A: The drug's primary action is bacteriostatic, meaning it suppresses bacterial population growth. It is important that the full prescribed course is completed, even if the person begins to feel better soon after starting treatment, to ensure the infection is fully cleared by the body's immune system.

Q: Does Doxycyclin Stada treat acne, and how effective is it?

A: Yes, regulatory labels state that Doxycycline is indicated for the treatment of inflammatory lesions associated with acne. Its effectiveness in treating acne is related to both its antibacterial properties and its anti-inflammatory effects on the skin.

Q: Can Doxycyclin Stada be used for malaria prevention?

A: Yes, Doxycycline is a drug that is formally approved and indicated for the prophylaxis, or prevention, of malaria, specifically when caused by the parasite Plasmodium falciparum.

Q: Why do some doctors prescribe Doxycyclin Stada for rosacea?

A: Doxycyclin is indicated for the treatment of inflammatory lesions of rosacea. This use is based on the drug's non-antibiotic effect, where it helps to reduce inflammation and tissue breakdown in the body, which is a key component of the rosacea condition.

Q: How long after taking Doxycyclin Stada can I eat dairy products?

A: Regulatory guidance for Doxycycline stresses that antacids and iron supplements (which contain minerals) must be separated from the dose by one to three hours to prevent impaired absorption. A separation guideline similar to other mineral-containing products (one to two hours) is often suggested for dairy due to its calcium content, though specific timing for dairy is not universally mandated in product labels.

Q: Does Doxycyclin Stada cause increased sensitivity to sunlight?

A: Yes, official warnings clearly state that Doxycycline can cause photosensitivity, which means an exaggerated, severe sunburn-like reaction when exposed to sun or UV light. Safety instructions generally recommend limiting sun exposure and seeking advice from a healthcare provider at the very first sign of skin redness (erythema).

Q: Is Doxycyclin Stada safe for teenagers with severe acne?

A: Official eligibility guidelines permit the use of Doxycycline in adolescents who are 12 years of age and older. Its use in this population, including for conditions like acne, is permissible according to eligibility rules.

Q: Are there any specific foods to avoid while taking Doxycyclin Stada?

A: The key restriction listed in regulatory documents involves mineral-containing preparations, as they can significantly impair the absorption of Doxycycline. This includes antacids, calcium supplements, iron products, and oral zinc, which must be taken with a separation interval of one to two hours from the Doxycyclin Stada dose.

Q: Is Doxycyclin Stada a strong antibiotic?

A: Doxycycline is officially classified as a 'broad-spectrum' antibiotic, meaning it is effective against a wide variety of bacterial types. Its primary action is described as bacteriostatic, which means it works by inhibiting the growth of bacteria rather than directly killing them.

Q: Why is Doxycyclin Stada often prescribed for Lyme disease?

A: Official information recognizes Doxycycline as a highly effective treatment for Lyme disease. It is often prescribed as a standard-of-care, first-line treatment for adults due to its high activity against the Borrelia bacteria that causes the disease.

Q: Are there different strengths of Doxycyclin Stada, and what are they used for?

A: Yes, Doxycycline is available in several strengths (e.g., 50 mg, 100 mg, 200 mg). Different strengths and specific formulations are prescribed for different medical needs, such as a lower dosage for long-term conditions like rosacea, or higher dosages for certain acute infections.

Q: What precautions should be taken when driving while on Doxycyclin Stada?

A: While specific driving precautions are not detailed, official safety information notes possible central nervous system side effects such as dizziness or lightheadedness. If a person experiences these effects, their ability to drive or operate complex machinery safely may be impaired, and caution is advised.

Q: Is there a generic version of Doxycyclin Stada available?

A: Yes, the active ingredient, Doxycycline, is widely available in generic forms, including capsules and tablets, from various manufacturers, as confirmed by regulatory and pharmaceutical information.

Q: How long does Doxycyclin Stada stay in your system after the last dose?

A: Regulatory pharmacokinetic data indicates that the half-life of Doxycycline (the time it takes for half of the drug to be eliminated) typically ranges from 16 to 22 hours in healthy adults. This means the medicine is generally cleared from the system completely within about five days after taking the last dose.

Q: Does Doxycyclin Stada have a bitter taste if the capsule is opened?

A: Regulatory guidelines often stress that the tablets or capsules should be swallowed whole without chewing or crushing. For formulations that can be sprinkled on food, instructions mandate immediate swallowing without chewing, which suggests the taste may be unpleasant or that chewing interferes with the medicine's designed action.

Q: Is there any research on Doxycyclin Stada's effectiveness against superbugs?

A: Official microbiology and clinical evidence sections address the drug's spectrum of activity against many types of bacteria. However, regulatory documents specifically emphasize that cross-resistance to other tetracyclines is common and that careful selection is required for treatment.

Q: Is Doxycyclin Stada suitable for people with a history of liver issues?

A: Regulatory documents advise caution for patients with current hepatic (liver) impairment. Doxycycline has been rarely associated with acute liver injury. In populations with pre-existing conditions, use of the drug is subject to close professional evaluation and monitoring.

Q: What information should I share with my doctor before starting Doxycyclin Stada?

A: Official consumer information advises sharing any health conditions, including any known hypersensitivities or allergies to tetracycline antibiotics. It is generally advised that individuals share a complete list of all current medicines, supplements, and vitamins.

Q: Why is Doxycyclin Stada sometimes used in combination with other drugs?

A: Doxycycline is used in combination with other drugs for specific medical reasons, such as for the treatment of mixed infections where multiple types of bacteria are suspected. For instance, combination regimens are sometimes explored to prevent the development of drug resistance in certain medical contexts.

How should Doxycyclin Stada be stored and disposed of?

Doxycyclin Stada must be stored according to official regulatory labeling to ensure product stability and prevent harm to children or the environment.

Official Storage Requirements

Condition Requirement (As per Regulatory Labeling)
Temperature Store at Controlled Room Temperature (20 to 25 C); Do not store above 25 C.
Protection Store in a dry place; The container must be light-resistant and kept tightly closed in the original package.
Child Safety Keep the medicine out of the sight and reach of children; Must be dispensed with a child-resistant closure.

Official Disposal Instructions

Any unused or expired Doxycyclin Stada must be disposed of in accordance with local requirements for pharmaceutical waste. The official labeling mandates not disposing of the product via wastewater or household waste to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Doxycyclin Stada found in:

A-Z Index: